Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Oct 28, 2026
TickeronGET DAILY SIGNALS
Axon (AXON) Analyst Targets Average $650, Pointing to +53% Upside

Axon (AXON) Analyst Targets Average $650, Pointing to +53% Upside

Key Takeaways

  • The central target is $650, the arithmetic mean of nine recent, attributed analyst price targets, with a wide range of roughly $470 to $800.
  • At a recent price near $425.87, reaching $650 would require a gain of about 53%—a very large move.
  • For context, broader aggregator consensus (roughly $680–$690) sits near or slightly above the calculated mean, reflecting similar but not identical coverage.
  • Key supports include roughly 30%-plus revenue growth, AI and drone expansion, and federal counter-drone (UAS) orders.
  • Principal risks are order and bookings volatility, software (SaaS) and margin concerns, and a rich valuation with a trailing P/E near 176.
  • The analyst range is unusually wide because bulls emphasize a large, underpenetrated market while cautious voices flag slowing orders and multiple compression.
  • For more detail on this ticker's Major News, Today's Price Move, Forecast, and Earnings, explore the dedicated pages.
  • To see how AI screens the broader market, explore Trending AI Robots.

Breaking Down the Analyst Price Targets

AXON is Axon Enterprise, Inc., a Nasdaq-listed maker of conducted energy weapons (TASER) and body-worn cameras, plus an expanding software, sensors, drone, and AI platform for public safety. Nine recent, individually attributed price targets were reviewed, spanning roughly $470 to $800. Their average is about $649, rounded to a $650 central target. At the top, Goldman Sachs (Michael Ng) and TD Cowen (Andrew Sherman) hold $800 Buy ratings. Raymond James (Brian Gesuale) and Morgan Stanley (Meta Marshall) sit at $675 with Outperform/Overweight ratings, while RBC Capital is at $735. In the middle, Needham (Joshua Reilly) is at $600, Piper Sandler (James Fish) at $561, and Barclays (Tim Long) at $523. The most cautious is UBS (Andrew Spinola) at $470 with a Neutral rating. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Notably, recent changes have been target cuts rather than rating downgrades. Piper Sandler lowered its target from $732 to $561 in October 2026, Raymond James from $800 to $675, UBS from $600 to $470, and TD Cowen from $825 to $800. Earlier in 2026, Barclays cut to $523, Needham to $600, and Morgan Stanley to $675. This pattern reflects a resetting of multiples across growth software rather than a collapse in the fundamental thesis.

Current Market Position and Path Toward the Target

AXON closed near $425.87 on October 27, 2026, toward the lower end of a 52-week range of roughly $339 to $764. The stock has fallen about 43% over the past year amid SaaS, M&A, and margin concerns. Reaching $650 from $425.87 implies roughly 53% upside—a very large move that would require both operational re-acceleration and multiple expansion. The path would likely run through improved quarterly bookings, evidence that software and services margins are stabilizing, and continued traction in AI-enabled products and counter-UAS demand. Because the shares trade at a trailing P/E near 176, sentiment and valuation, not just results, would need to recover.

What Could Support a Move Toward the Target

AXON has sustained roughly 30%-plus revenue growth, with management guiding to continued expansion across TASER, sensors, and software. Analysts point to a large, underpenetrated total addressable market, sticky public-safety customers, cross-selling into new verticals such as retail and healthcare, and new products including the Axon Body Workforce Mini. Federal counter-UAS orders and higher-margin AI software, along with acquisitions of Carbyne and Prepared to modernize 911 operations, are cited as growth drivers. A stronger fourth quarter and clearer FY26 guidance could support a re-rating.

What Could Prevent the Target From Being Reached

The primary obstacle is execution risk. Recent quarters showed disappointing orders and bookings, with timing-related weakness in software and services. Valuation compression is a real threat for a stock trading near 176 times trailing earnings, particularly if interest rates stay elevated or growth software multiples reset further. Government budget cycles, regulation, and intensifying competition could also pressure growth. If bookings remain soft or margins fail to expand, the premium multiple may not recover even with solid revenue growth.

Technical Levels and Market Structure

AXON trades well below its 52-week high near $764, leaving meaningful overhead supply. The $500 level is a key psychological hurdle, followed by resistance in the $560–$600 zone where several lowered targets cluster. On the downside, the $400 area has provided recent support, with the 52-week low near $339 as a more durable floor. Reaching $650 would require clearing the $500 and $600 zones decisively—levels that align with the cautious end of the analyst range.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a roughly 12-month research horizon, though individual timelines vary. The next major catalyst is Axon's third-quarter 2026 earnings report, scheduled around November 5, 2026, followed by fourth-quarter and full-year guidance. Investors should also watch bookings and order trends, software and services margins, AI and drone adoption, federal budget and counter-UAS awards, analyst target revisions, and the path of interest rates given the stock's sensitivity to growth multiples. From what I see, this is important because the upcoming print could shift sentiment quickly.

Integrating AI Signals into My Research

For traders tracking momentum alongside fundamentals, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to analyst research. The system uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. I find these signals helpful for surfacing opportunities and monitoring shifts without replacing core fundamental work.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AXON

AXON's RSI Indicator descends into oversold zone

The RSI Indicator for AXON moved into overbought territory on November 20, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 270 of 367 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXON as a result. In 52 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

The Moving Average Convergence Divergence Histogram (MACD) for AXON turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 27 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

The 50-day moving average for AXON moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

The Aroon Indicator for AXON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. AXON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.920) is normal, around the industry mean (5.050). AXON has a moderately high P/E Ratio (126.721) as compared to the industry average of (17.247). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.367).

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 36.83B. The market cap for tickers in the group ranges from 4.49 to 1.77T. SPCX holds the highest valuation in this group at 1.77T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -16%. For the same Industry, the average monthly price growth was -17%, and the average quarterly price growth was -35%. POWW experienced the highest price growth at 13%, while VWAV experienced the biggest fall at -55%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 41%. For the same stocks of the Industry, the average monthly volume growth was 16% and the average quarterly volume growth was -22%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 53
Price Growth Rating: 65
SMR Rating: 78
Profit Risk Rating: 79
Seasonality Score: -14 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company

Industry AerospaceDefense

Industry
Biotechnology
Address
17800 North 85th Street
Phone
+1 480 991-0797
Employees
6300
Web
https://www.axon.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.